Whole Exome Sequencing Market Key Opportunities to 2027

1
Whole Exome Sequencing Market
Publication Month Aug 2019 Report Code
TIPRE00005519 No. of Pages 178 Category
Biotechnology Status Published
Whole Exome Sequencing Market to 2025 - Global
Analysis and Forecasts by Product (Intermittent
Catheters, Urinary Bags, Male External Catheters,
Bowel Management, Others) Applications (Spinal
Cord Injury, Benign Prostate Hyperplasia,
Others) and End Users (Long-Term Care
Facilities, Hospitals, and Others)
E-Mail  sales_at_theinsightpartners.com
2
Whole Exome Sequencing Market
Publication Month Aug 2019 Report Code
TIPRE00005519 No. of Pages 178 Category
Biotechnology Status Published
Introduction The global Whole exome sequencing
market accounted to US 755.68 Mn in 2018 and is
expected to grow at a CAGR of 19.8 during the
forecast period 2019 2027, to account to US
3,812.0 Mn by 2027.   Asia Pacific is the fastest
growing geographic market and it is expected to
be the fastest revenue contributor throughout the
forecast period. Asia Pacific is recognized as a
developing market for the biotechnology. The
growth is driven by countries such as China, and
India which are engaged in conducting several
studies.
E-Mail  sales_at_theinsightpartners.com
3
Whole Exome Sequencing Market
Publication Month Aug 2019 Report Code
TIPRE00005519 No. of Pages 178 Category
Biotechnology Status Published
Reduction in Time and Cost for Sequencing The
exon is part of a genome which is responsible for
making 1 or 2 percent of the entire genome of a
person. All of the exon in a genome are together
known as the exome. And thus, sequencing is of
these is known as whole-exome sequencing. The
whole-exome sequencing allows identifying the
variations in the protein-coding sites of any
gene compared to sequencing a few genes together.
The whole-exome sequencing is preferred widely
due to its property to identify a mutation in a
single exon. Identifying mutation in at the
original site makes whole-exome sequencing an
efficient method and enable to identify possible
disease-causing mutation.   The advancement in
the field of genomics has led to a significant
reduction in the time and cost of genome
sequencing. The related cost of sequencing with
different sequencing techniques and strategies
are of interest as they influence the scope and
scale of the genomic research studies. Thus, it
makes whole-exome sequencing much-preferred
method than whole-genome sequencing.   The
advantages of exome sequencing have resulted in
the reduction of time and cost to a great extent.
Approximately 2 of the genome is sequenced by
the WES method however, it generally sequences
the exon at a deeper level it sequence to 100X.
The technique enables sequencing through a
process where the DNA and RNA are hybridized with
the protein-coding site and is isolated from the
non-coding site. Also, the data required for 100X
sequencing is approximately 5- 6GB, whereas, in
genome sequencing, it is nearly 90GB. Thus, these
factors offer lower data storage, faster,
cheaper, and more accessible data analysis.
Therefore, owing to the above-mentioned factors,
it is estimated that the market for whole-exome
sequencing is likely to grow significantly during
the forecast period.
E-Mail  sales_at_theinsightpartners.com
4
Whole Exome Sequencing Market
Publication Month Aug 2019 Report Code
TIPRE00005519 No. of Pages 178 Category
Biotechnology Status Published
Rising Need of Molecular Diagnosis The
whole-exome sequencing has been accepted as an
advanced sequencing technique due to its
advantages. Due to the benefits of whole-exome
sequencing, it is used as a diagnostic tool in
regular practice. The technique is mainly used to
diagnose genetic diseases and cancer. The use of
exome sequencing is offered genetic analysis that
allows appropriate treatment, management,
inheritance, and efficient decision making.   The
whole-exome sequencing technique is used as it
provides information on clinically covered all
genes. The technique analyzes conditions for
single gene and multi gene disorders. The
whole-exome sequencing technique is considered
ideal for targeted management of complex
conditions such as epilepsy, ASDs, neuropathy,
and other genetic diseases. In addition, the
whole-exome sequencing allows complete analysis
of nearly 23,000 genes in the human genome with
the help of next-generation sequencing in a
single run.   The whole-exome sequencing is a
short-term substitute for receiving an image of a
genome that is being coded. Whole-exome
sequencing is attractive in the fields of
research, diagnostics, and clinical setting. The
whole-exome sequencing is used for identifying
variants in both all the disease types and in
SNPs associations and pharmacogenetics.   Thus,
the wide application of the whole-exome
sequencing in the field of molecular diagnostics
and clinical diagnostics are likely to influence
the growth of the market during the forecast
period.
E-Mail  sales_at_theinsightpartners.com
5
Whole Exome Sequencing Market
Publication Month Aug 2019 Report Code
TIPRE00005519 No. of Pages 178 Category
Biotechnology Status Published

• The List of Companies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Centogene AG
• F. Hoffmann-La Roche AG
• Psomagen, Inc. (previuosly Macrogen Corp.)
• Pacific Biosciences of California, Inc.
• Brooks Automation, Inc. (GENEWIZ, Inc.)
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• Stratos Genomics

Get Sample PDF Brochure
E-Mail  sales_at_theinsightpartners.com